These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism. Culp-Hill R, Srinivasan AJ, Gehrke S, Kamyszek R, Ansari A, Shah N, Welsby I, D'Alessandro A. Transfusion; 2018 Dec; 58(12):2797-2806. PubMed ID: 30265764 [Abstract] [Full Text] [Related]
6. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease. Schroeder P, Fulzele K, Forsyth S, Ribadeneira MD, Guichard S, Wilker E, Marshall CG, Drake A, Fessler R, Konstantinidis DG, Seu KG, Kalfa TA. J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585 [Abstract] [Full Text] [Related]
12. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC. Drawz P, Ayyappan S, Nouraie M, Saraf S, Gordeuk V, Hostetter T, Gladwin MT, Little J. Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):207-15. PubMed ID: 26672090 [Abstract] [Full Text] [Related]
19. More efficient exchange of sickle red blood cells can be achieved by exchanging the densest red blood cells: An ex vivo proof of concept study. Thibodeaux SR, Tanhehco YC, Irwin L, Jamensky L, Schell K, O'Doherty U. Transfus Apher Sci; 2019 Feb 05; 58(1):100-106. PubMed ID: 30616959 [Abstract] [Full Text] [Related]